Implantable cardiac defibrillators are recommended in high-risk patients i.e, patients with dilated cardiomyopathy for the primary prevention of<unk><unk><unk> .
Pulseless ventricular tachycardia primary prevention
Ventricular tachycardia primary prevention
Ventricular tachycardia future or investigational therapies
Ventricular tachycardia secondary prevention
ST elevation myocardial infarction secondary prevention
Atrial fibrillation primary prevention
Pulseless ventricular tachycardia medical therapy
Atrial fibrillation secondary prevention